Screener
Inhibrx Biosciences, Inc. INBX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$36.65M-27.9% | -$33.44M+22.8% | -$32.83M— | -$35.26M+19.6% | -$28.65M-102% | ||
| $517K-11.8% | $537K-20.4% | $564K-18.1% | $582K-23.4% | $586K+23.4% | ||
| $3.1M+12.1% | $2.65M+8.3% | $2.74M-8.0% | $3.18M+7.1% | $2.77M-94.0% | ||
| -$29.92M+0.1% | -$38.03M-5.9% | -$30.12M+31.1% | -$33.82M-11.7% | -$29.95M+47.8% | ||
| $0— | $0-100% | —— | $10K-96.0% | —— | ||
| $0— | $0+100% | —— | -$7K+97.2% | —— | ||
| $1.6M— | $75.46M-24.4% | $1.25M— | $352K— | $0-100% | ||
| —— | $37.44M-41.4% | -$28.87M+34.0% | —— | —— | ||
| -$29.92M+0.1% | -$38.03M-5.9% | -$30.12M+31.1% | -$33.83M-10.8% | -$29.95M+48.9% |
FAQ
- How much cash does Inhibrx Biosciences, Inc. generate?
- Inhibrx Biosciences, Inc. (INBX) generated -$131.9M in operating cash flow over the trailing twelve months.
- What is Inhibrx Biosciences, Inc.'s free cash flow?
- After $31.0K of capital expenditures, Inhibrx Biosciences, Inc.'s free cash flow was -$131.9M over the trailing twelve months, up 5.9% year over year.
- Where does Inhibrx Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
